These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 31718358

  • 1. Comparison of Ranibizumab versus Aflibercept in Treating Macular Edema among Patients with Serous Retinal Detachment Secondary to Branch Retinal Vein Occlusion.
    Küçük B, Sirakaya E, Karaca C.
    Ocul Immunol Inflamm; 2021 Feb 17; 29(2):403-410. PubMed ID: 31718358
    [Abstract] [Full Text] [Related]

  • 2. Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.
    Pichi F, Elbarky AM, Elhamaky TR.
    Int Ophthalmol; 2019 Jan 17; 39(1):145-153. PubMed ID: 29274022
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
    Kaldırım HE, Yazgan S.
    Int Ophthalmol; 2018 Aug 17; 38(4):1549-1558. PubMed ID: 28646440
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aflibercept Treatment for Macular Edema following Branch Retinal Vein Occlusion: Age-Based Responses.
    Sırakaya E, Küçük B, Ağadayı A.
    Ophthalmologica; 2020 Aug 17; 243(2):94-101. PubMed ID: 31461723
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study.
    Khurana RN, Chang LK, Bansal AS, Palmer JD, Wu C, Wieland MR.
    Ophthalmol Retina; 2018 Feb 17; 2(2):128-133. PubMed ID: 31047339
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab.
    Konidaris V, Al-Hubeshy Z, Tsaousis KT, Gorgoli K, Banerjee S, Empeslidis T.
    Int Ophthalmol; 2018 Feb 17; 38(1):207-213. PubMed ID: 28405787
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept-A Prospective Study.
    Huang YT, Wang I, Lin CJ, Lai CT, Hsia NY, Chen HS, Tien PT, Bair H, Lin JM, Chen WL, Chen CH, Wu WC, Tsai YY.
    Medicina (Kaunas); 2022 Apr 14; 58(4):. PubMed ID: 35454378
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion.
    Ozgonul C, Dedania VS, Besirli CG.
    J Ocul Pharmacol Ther; 2018 May 14; 34(4):340-345. PubMed ID: 29447089
    [Abstract] [Full Text] [Related]

  • 17. Current Outcomes of Anti-VEGF Therapy in the Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusions: A Meta-Analysis.
    Spooner K, Hong T, Fraser-Bell S, Chang AA.
    Ophthalmologica; 2019 May 14; 242(3):163-177. PubMed ID: 31158837
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Li F, Sun M, Guo J, Ma A, Zhao B.
    Curr Eye Res; 2017 Aug 14; 42(8):1174-1178. PubMed ID: 28441077
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.
    Noma H, Funatsu H, Mimura T, Shimada K.
    BMC Ophthalmol; 2012 Aug 09; 12():39. PubMed ID: 22876931
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.